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http://dx.doi.org/10.1016/j.fjs.2012.Summary A giant cell tumor (GCT) is a benign but locally aggressive bone neoplasm. It rarely
involves the squamous portion of the temporal bone. Its diagnosis is challenging since patients
with a GCT present with a nonspecific osteolytic lesion of the temporal bone. In this paper, we
report a pathologically confirmed case of GCT that was confined to the squama of the right
temporal bone. The diagnosis was established after resection. The residual tumor was later
controlled by intensity-modulated radiotherapy, which resulted in significant tumor
regression.
Copyright ª 2012, Taiwan Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Giant cell tumors (GCTs) of the bone account for 5% of all
primary bone tumors.1 A GCT usually arises in the meta-
physeal region of the long bones (e.g., distal femur, prox-
imal tibia, distal radius), but it is rare in the cranium.2 It
most often occurs at the age of 30e40 years, after skeletal
maturation has finished.2,3 For unknown reasons, theof Neurological Surgery, Tri-
efense Medical Center, No.
eihu District, Taipei 11404,
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10.006incidence of GCTs in females is higher than in males.2,4 In
this article we present a 62-year-old woman with a giant
cell tumor of the squama of the right temporal bone.2. Case report
A 62-year-old female presented with a 3-month history of
headache, dizziness, and an unstable gait. The general
physical examinations were essentially normal, except for
a palpable, nontender, hard, protruding mass in the right
temporal region. Neurological examinations revealed no
obvious abnormality. A computed tomography (CT) scan of
the brain showed an osteolytic lesion of the right temporal
bone that was expanding the outer table of the skull andciation. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 1 Radiologic imaging. (A) Computed tomography (CT) scan shows an expansile, destructive soft-tissue lesion involving the
squamous portion of the right temporal bone. (B) The postoperative 7-month cranial magnetic resonance imaging shows a non-
enhancing lesion with heterogeneous signal. It measured 4.2 cm  2.4 cm  3.8 cm and invaded the right middle fossa.
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nance imaging (MRI) showed a nonenhancing lesion
(measuring 4.2 cm  2.4 cm  3.8 cm) with a heteroge-
neous signal that was invading the right middle cranial fossa
(Fig. 1B). The patient underwent surgical resection of the
bony mass from the right temporal bone through a right
preauricular incision. The gross examination showed that
the tumor was yellow-brown with soft and firm compo-
nents. The tumor invaded the squamous temporal bone
superiorly and medially. It involved the dura but not the
brain. A subtotal removal of the tumor was achieved. The
patient’s postoperative course was uneventful. No neuro-
logical complications occurred. Histopathological exami-
nations demonstrated multinucleated giant cells that were
diffusely distributed in a background of plump mononuclear
spindle cells (Fig. 2). This finding was consistent with
a diagnosis of GCT. The patient was subsequently treated
for the residual tumor by intensity-modulated radiotherapyFigure 2 Microscopic photograph showing multinucleated
giant cells and mononuclear histiocytic cells (hematoxylin and
eosin staining; original magnification, 400).(IMRT) with a total dose of 60 grays (Gy). Fourteen months
after IMRT, a follow-up MRI of the brain showed regression
of the tumor.
3. Discussion
This is a case of GCT in a very rare locationdthe squama of
the right temporal bone with involvement of the right
infratemporal fossa. To our knowledge, GCTs are relatively
benign bone tumors that make up 3e7% of primary bone
tumors.2,4,5 According to some case reports, a GCT can be
locally aggressive with a potential for malignant trans-
formation and distant metastases.2,3 The majority of GCTs
usually occur at the epiphysis of long bones such as the
distal femur, proximal tibia and fibula, distal radius and
ulna, and knee joints.2 The cranium, however, is quite
a rare location for a GCT.1,5 In the skull, the sphenoid bone
is the most common site, followed by the temporal
bone.1,4,5 Only seven cases have been reported in the past
24 years that demonstrate that these benign locally
destructive lesions may involve the temporal bone with
extension into the middle cranial fossa.6 A GCT in general
occurs in the age range of 30e50 years and only rarely
occurs before 20 years or after 70 years of age.2,3 A female
predominance is often reported in the younger age group.1
A temporal bone GCT usually is clinically silent. The tumor
grows insidiously and is likely to attain a large size before
clinical symptoms occur. The symptoms consist of pain,
swelling in the region of the affected bone, and limited
motion of the adjacent joint. Tumors arising from the
temporal bone typically cause deafness, facial weakness,
and pain behind the affected ear.5,7,8 Imaging diagnosis is
difficult since this tumor lacks specific radiologic features.
The most frequent radiologic finding is an expansive and
sometimes destructive bone lesion that may extend to
adjacent soft tissues, the dura mater, or the sinuses.
Intracranial extension may also be present.4,8 The radio-
logical differential diagnosis includes giant cell reparative
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tumors of hyperparathyroidism, chondrosarcoma, osteo-
lytic metastasis, and other fibro-osseous lesions.4,5,8 A
computed tomographic scan may demonstrate an osteolytic
lesion expanding the bone cortex and the presence of a soft
tissue component. Before surgery, magnetic resonance
imaging is the ideal tool to assess the integrity of the
surrounding soft tissue (including neurovascular structures)
and to assess tumor extension into the soft tissue. A GCT
shows low to intermediate signals on T1-weighted spin echo
images and shows intermediate to high signals on T2-
weighted images. Heterogeneous enhancement is present
after the intravenous administration of gadolinium.4,8
Giant cell tumors histologically have a predominance of
large multinucleated giant cells that are dispersed in
spindle-shaped stroma cells. However, other types of
tumors are also rich in giant cells such as chondro-
blastomas, aneurysmal bone cysts, and giant-cell repara-
tive granulomas.1,7 This feature makes determining
a correct pathological diagnosis difficult.
Because of the scarcity of temporal GCT case reports,
the precise therapeutic roles of the extent of surgery and
adjuvant therapies remain unestablished.2 A complete
surgical excision is generally the gold standard of treat-
ment.7 According to previous articles in the medical liter-
ature, the local recurrence rate varies widely from 7% to
60% and depends on the extent of surgery (e.g., en bloc
resection or curettage only).2,5,7 For good local control,
a wide local excision is preferred as the first step. However,
en bloc resection for a cranial GCT is often difficult and may
cause cosmetic or neurologic deficits. The role of post-
operative radiation is still controversial. In some series,
adjuvant radiotherapy reportedly produces good local
control (from 80% to 90%).9 Some scientists believe,
however, that radiation may induce a future malignant
transformation.10
Giant cell tumors of the temporal bones are rare. Even
with currently available imaging tools, it remains difficult
to differentiate an osteolytic cranial lesion involving thetemporal bone from other more common neoplasms. A wide
surgical excision can provide good local control. However,
en bloc resection of a temporal GCT is difficult. Adjuvant
radiotherapy for the residual tumor after the subtotal
resection produced significant tumor regression for 14
months in our patient. Long-term follow up will be required
to evaluate the final outcome of our patient.References
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